Jiangzhong Pharmaceutical announces results of stock incentive plan grant

Jiangzhong Pharmaceutical (SSE:600750) announced the successful first grant of its second phase restricted stock incentive plan, with a record date of June 6, 2025. The company granted 612.8 million shares at a price of CNY 13.70 per share to 165 eligible employees, fewer than the initially planned 168, due to voluntary forfeitures. The shares come from the company's issuance of ordinary A-shares. The incentive plan aims to boost performance, setting targets for return on invested capital, net profit growth, and R&D spending for the years 2025-2027. Tianzhi International Accountants confirmed the receipt of CNY 83,953,600 for the share subscriptions, which will be used to replenish the company's working capital. After the grant, China Resources Jiangzhong Pharmaceutical Group will see its stake diluted to 42.84%.